Pα+ Psychedelic Bulletin #208: Psychedelic CEOs’ FDA Wish-List; APA Division 56 President Talks Psychedelics; Compass’ PTSD Study Published; Cybin Ousts Drysdale

Psychedelic Science in Denver feels like many moons ago. Indeed, it’s been a blur since: right after the conference wrapped, Compass Pathways shared a topline readout from its first Phase 3 program, then Beckley Psytech shared results from its Phase 2b study, then Germany established the EU’s first psilocybin compassionate use program, then the AbbVie-Gilgamesh rumour mill fired up again…

Source